Kisspeptin Promotes Breast Cancer Invasion
Author Information
Author(s): Zajac Mateusz, Law Jeffrey, Cvetkovic Dragana Donna, Pampillo Macarena, McColl Lindsay, Pape Cynthia, Di Guglielmo Gianni M., Postovit Lynne M., Babwah Andy V., Bhattacharya Moshmi
Primary Institution: The University of Western Ontario
Hypothesis
Does kisspeptin signaling promote breast cancer cell invasiveness and what are the underlying mechanisms?
Conclusion
Kisspeptin-10 stimulates breast cancer cell invasiveness through the transactivation of the epidermal growth factor receptor.
Supporting Evidence
- Kisspeptin-10 significantly stimulated cell invasion in breast cancer cell lines.
- Kisspeptin-10 increased MMP-9 activity, which is associated with cancer invasiveness.
- Kisspeptin-10 transactivates EGFR, which is crucial for promoting breast cancer cell invasion.
- Knockdown of β-arrestin 2 inhibited kisspeptin-induced invasion and EGFR transactivation.
Takeaway
Kisspeptin helps breast cancer cells move and invade more, which is important for cancer spreading.
Methodology
The study used Transwell chamber assays and three-dimensional invasion assays to assess the effects of kisspeptin-10 on breast cancer cell invasion.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website